Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

NCT04400591 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

BIOLOGICAL: Nonconforming Lisocabtagene Maraleucel

Sponsor

Juno Therapeutics, a Subsidiary of Celgene